GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Machinery, Furniture, Equipment

SOLTF (Nxera Pharma Co) Machinery, Furniture, Equipment : $0.0 Mil (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Machinery, Furniture, Equipment?

Nxera Pharma Co's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2025 was $0.0 Mil.


Nxera Pharma Co Machinery, Furniture, Equipment Historical Data

The historical data trend for Nxera Pharma Co's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Machinery, Furniture, Equipment Chart

Nxera Pharma Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Machinery, Furniture, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nxera Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Machinery, Furniture, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nxera Pharma Co Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


Nxera Pharma Co Business Description

Traded in Other Exchanges
Address
Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).